Story perspectives

Alcor Faces Competition Amid Push for Female Membership

3/20/2026

Summary

Story summary

Alcor, founded in 1972, faces increasing competition from Tomorrow Bio and Until Labs.
Arrowood, Alcor's CEO, cites decades of cryopreservation data as Alcor's advantage, despite skepticism.
Alcor has 250 preserved patients, including its founder, and counts Peter Thiel among wealthy members.
In 2024, user service fees accounted for 40% of Alcor's $4 million revenue.
Arrowood aims to increase female membership, which is currently one-third of total members.

1 of 1

Story summary

Alcor, founded in 1972, faces increasing competition from Tomorrow Bio and Until Labs.
Arrowood, Alcor's CEO, cites decades of cryopreservation data as Alcor's advantage, despite skepticism.
Alcor has 250 preserved patients, including its founder, and counts Peter Thiel among wealthy members.
In 2024, user service fees accounted for 40% of Alcor's $4 million revenue.
Arrowood aims to increase female membership, which is currently one-third of total members.